OPK Opko Health Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: OPK

Price (delayed)

$1.66

Market cap

$1.23B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.19

Enterprise value

$1.35B

Sign up for free to view scoring metrics ?
Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 29

OPKO Health, Inc. (OPKO) is a multi-national pharmaceutical and diagnostics company. OPKO is developing a range of solutions to diagnose, treat and prevent various conditions, including molecular diagnostics tests, point-of-care ...

Highlights
Opko Health's gross margin has increased by 19% YoY
The gross profit has grown by 10% YoY and by 3.1% from the previous quarter
Opko Health's EPS has plunged by 111% from the previous quarter but it has increased by 21% YoY
The net income has dropped by 103% since the previous quarter but it is up by 18% year-on-year
The debt has increased by 32% YoY and by 30% QoQ
Opko Health's equity has decreased by 15% YoY and by 6% QoQ
Sector: Healthcare
Industry: Diagnostics & Research
Website: http://www.opko.com
Peers: JNJ ABT REGN ARDX

Key stats

What are the main financial stats of OPK

OPK stock price

How has the Opko Health stock price performed over time
Intraday
-2.92%
1 week
-5.14%
1 month
20.29%
1 year
25.76%
YTD
31.75%
QTD
3.11%

Financial performance

How have Opko Health's revenue and profit performed over time
Revenue
$501.64M
Gross profit
$231.86M
Operating income
-$127.72M
Net income
-$148.06M
Gross margin
46.2%
Net margin
-29.5%
The net income has dropped by 103% since the previous quarter but it is up by 18% year-on-year
The net margin has shrunk by 99% QoQ but it has increased by 11% YoY
The operating income has grown by 34% YoY
OPK's operating margin is up by 28% year-on-year and by 3.4% since the previous quarter

Price vs fundamentals

How does OPK's price correlate with its fundamentals

Growth

What is Opko Health's growth rate over time

Valuation

What is Opko Health stock price valuation
P/E
N/A
P/B
1.11
P/S
2.47
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.7
Opko Health's EPS has plunged by 111% from the previous quarter but it has increased by 21% YoY
The P/B is 27% above the 5-year quarterly average of 0.9 and 27% above the last 4 quarters average of 0.9
Opko Health's equity has decreased by 15% YoY and by 6% QoQ
The P/S is 69% above the 5-year quarterly average of 1.5 and 27% above the last 4 quarters average of 2.0
The company's revenue fell by 8% YoY

Efficiency

How efficient is Opko Health business performance
Opko Health's ROS has plunged by 112% from the previous quarter and by 94% YoY
The ROE has shrunk by 110% QoQ but it has increased by 9% YoY
The ROA has plunged by 108% from the previous quarter but it has grown by 9% YoY
OPK's ROIC has dropped by 95% since the previous quarter and by 62% year-on-year

Dividends

What is OPK's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OPK.

Financial health

How did Opko Health financials performed over time
The company's total assets is 146% higher than its total liabilities
Opko Health's current ratio has increased by 48% from the previous quarter and by 34% YoY
OPK's total liabilities is up by 18% since the previous quarter and by 11% year-on-year
The debt is 54% lower than the equity
The debt to equity has soared by 53% year-on-year and by 39% since the previous quarter
The debt has increased by 32% YoY and by 30% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.